The acoustic properties of two clinical (Definity, Lantheus Medical Imaging, North Billerica, MA, USA; SonoVue, Bracco S. P. A., Milan, Italy) and one pre-clinical (MicroMarker, untargeted, Bracco, Geneva, Switzerland; VisualSonics, Toronto, ON, Canada) ultrasound contrast agent were characterized using a broadband substitution technique over the ultrasound frequency range 12-43 MHz at 20 +/- 1 degrees C. At the same number concentration, the acoustic attenuation and contrast-to-tissue ratio of the three native ultrasound contrast agents are comparable at frequencies below 30 MHz, though their size distributions and encapsulated gases and shells differ. At frequencies above 30 MHz, native MicroMarker has higher attenuation values and contrast-to-tissue ratios than native Definity and SonoVue. Decantation was found to be an effective method to alter the size distribution and concentration of native clinical microbubble populations, enabling further contrast enhancement for specific pre-clinical applications. (E-mail: firstname.lastname@example.org) (C) 2014 World Federation for Ultrasound in Medicine & Biology.
|Number of pages||10|
|Journal||Ultrasound in Medicine and Biology|
|Publication status||Published - Mar 2014|
- High-frequency ultrasound
- Contrast-to-tissue ratio
- HIGH-FREQUENCY ULTRASOUND
- SIZE DISTRIBUTION
FingerprintDive into the research topics of '<em>In Vitro</em> acoustic characterization of three phospholipid ultrasound contrast agents from 12 to 43 MHz'. Together they form a unique fingerprint.
- School of Engineering & Physical Sciences - Associate Professor
- School of Engineering & Physical Sciences, Institute of Biological Chemistry, Biophysics and Bioengineering - Associate Professor
Person: Academic (Research & Teaching)